While non-exhaustive, this list offers an overview of the year’s biotech events taking place around the world, aimed at partnering and connecting with decision makers in biopharma. If there is a ...
A new wave of metabolic disease drugs beyond GLP-1 agonists is emerging to address the unmet needs of patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback